Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit

Journal of Neuroscience

Volumn 20, Issue 14, 2000, Pages 5321-5328

  Beaulieu, Jean Martin ^a   Jacomy, Hélène ^a,b   Julien, Jean Pierre ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

Author keywords

ALS; Amyotrophic lateral sclerosis; Intermediate filament; Motor neuron disease; Neurodegeneration; Neurofilament; Peripherin; Transgenic mouse

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE OVEREXPRESSION; MOUSE; NEUROFILAMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

EID: 0034662120     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-14-05321.2000     Document Type: Article

References (40)

1. Athlan ES, Mushynski WE (1997) Heterodimeric associations between neuronal intermediate filament proteins. J Biol Chem 272:31073-31078.
2. Beaulieu JM, Nguyen MD, Julien JP (1999a) Late onset death of motor neurons in mice overexpressing wild-type peripherin. J Cell Biol 147:531-544.
3. Beaulieu JM, Robertson J, Julien JP(1999b) Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits. Biochem Cell Biol 77:41-45.
4. Bergeron C, Beric-Maskarel K, Muntasser S, Weyer L, Somerville MJ, Percy ME (1994) Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J Neuropathol Exp Neurol 53:221-230.
5. Carpenter S (1968) Proximal axonal enlargement in motor neuron disease. Neurology 18:841-851.
6. Ching GY, Liem RKH (1993) Assembly of type IV neuronal intermediate filaments in nonncuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J Cell Biol 122:1323-1335.
7. Ching GY, Chien CL, Flores R, Liem RKH (1999) Overexpression of a-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice. J Neurosci 19:2974-2986.
8. Chou SM (1995) Pathology of motor system disorder. In: Motor neuron disease: biology and management (Leigh PN, Swash M, eds), pp53-92. London: Springer.
9. Cleveland DW (1999) From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24: 515-520.
10. Corbo M, Hays AP (1992) Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J Neuropathol Exp Neurol 51:531-537.
11. Côté F, Collard JF, Julien JP (1993) Progressive neuropathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73:35-46.
12. Crapper McLachlan DR, Lukiw WJ, Wong L, Bergeron C, Bech-Hansen NT (1988) Selective messenger RNA reduction in Alzheimer's disease. Mol Brain Res 3:255-262.
13. Croul S, Mezitis SG, Sticber A, Chen YJ, Gonatas JO, Goud B, Gonatas NK (1990) Immunocytochemical visualization of the Golgi apparatus in several species, including human, and tissues with an antiserum against MG-160, a sialoglycoprotein of rat Golgi apparatus. Histochem Cytochem 38:957-963.
14. Eyer J, Peterson A (1994) Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein. Neuron 12:389-405.
15. Fuchs E, Weber K (1994) Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 63:345-382.
16. Hoffman PN, Lasek RJ (1975) The slow component of axonal transport. J Cell Biol 642:316-322.
17. Houseweart MK, Cleveland DW (1999) Bcl-2 overexpression does not protect neurons from mutant neurofilament-mediated motor neuron degeneration. J Neurosci 19:6446-6456.
18. Jacomy H, Zhu Q, Couillard-Després S, Beaulieu JM, Julien JP (1999) Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits. J Neurochem 73:972-984.
19. Julien J (1997) Neurofilaments and motor neuron disease. Trends Cell Biol 7:243-249.
20. Julien JP, Mushynski WE (1983) The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments. J Biol Chem 258:4019-4025.
21. Julien JP, Trerjakoff I, Beaudet L, Peterson A (1987) Expression and assembly of a human neurofilament protein in transgenic mice provide a novel neuronal marking system. Genes Dev 1:1085-1095.
22. Kriz J, Meier J, Julien JP, Padjen AL (2000) Altered ionic conductances in axons of transgenic mouse expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Exp Neurol, in press.
23. Lee MK, Xu Z, Wong PC, Cleveland DW (1993) Neurofilaments are obligate heteropolymers in vivo. J Cell Biol 122:1337-1350.
24. Lee MK, Marszalek JR, Cleveland DW (1994) A mutant neurofilament subunit causes massive, selective motor neuron death: Implication for the pathogenesis of human motor neuron disease. Neuron 13:975-988.
25. Levavasseur F, Zhu Q, Julien JP (1999) No requirement of α-internexin for nervous system development and for radial growth of axons. Mol Brain Res 69:104-112.
26. Marszalek JR, Williamson TL, Lee MK, Xu Z, Hoffman PN, Becher MW, Crawford TO, Cleveland DW (1996) Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport. J Cell Biol 135:711-724.
27. Meier J, Couillard Despres S, Jacomy H, Gravel C, Julien JP (1999) Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J Neuropathol Exp Neurol 58:1099-1110.
28. Migheli A, Pezzulo T, Attanasio A, Schiffer D (1993) Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab Invest 68:185-191.
29. Pachter JS, Liem RK (1985) alpha-Internexin, a 66-kD intermediate filament-binding protein from mammalian central nervous tissues. J Cell Biol 101:1316-1322.
30. Parhad IM, Scott JN, Cellars LA, Bains JS, Krekoski CA, Clark AW (1995) Axonal atrophy in aging is associated with a decline in neurofilament gene expression. J Neurosci Res 41:355-366.
31. Parysek LM, Goldman RD (1988) Distribution of a novel 57 kDa intermediate filament (IF) protein in the nervous system. J Neurosci 8:555-563.
32. Parysek LM, McReynolds MA, Goldman RD, Ley CA (1991) Some neural intermediate filaments contain both peripherin and the neurofilament proteins. J Neurosci Res 30:80-91.
33. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown Jr RH, Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee M K, Valentine JS, Bredesen DE (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
34. Sternberger LA, Sternberger NH (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 80:6126-6130.
35. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM (1996) Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 93:3155-3160.
36. Tu PT, Robinson KA, de Snoo F, Eyer J, Peterson A, Lee VMY, Trojanowski JQ (1997) Selective degeneration of Purkinje cells with lewy body-like inclusions in aged NFHLACZ transgenic mice. J Neurosci 17:1064-1074.
37. Williamson TL, Bruijn LI, Zhu Q, Anderson KL, Anderson SD, Julien JP, Cleveland DW (1998) Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA 95:9631-9636.
38. Wong PC, Marszalek J, Crawford TO, Xu Z, Hsieh ST, Griffin JW, Cleveland DW (1995) Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons. J Cell Biol 130:1413-1422.
39. Xu Z, Cork LC, Griffin JW, Cleveland DW (1993) Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73:23-33.
40. Zhu Q, Couillard-Despres S, Julien JP (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 148:299-316.